Department of Thoracic and Vascular Surgery, University Hospital Antwerp, Edegem, Antwerp, Belgium.
Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium.
BMJ Case Rep. 2021 Jan 25;14(1):e238375. doi: 10.1136/bcr-2020-238375.
Sclerosing pneumocytomas are rare, benign pulmonary neoplasms that predominantly affect Asian female patients in the age category of 40-70 years, mostly non-smokers. We report on a 72-year-old Caucasian woman with chondrosarcoma of the hand who developed multiple bilateral progressive lung nodules suspicious of lung metastases. Staged lung resections were performed, and pathological diagnosis was confirmed by immunohistochemical analysis of the resected specimens. Next-generation sequencing (NGS) was used to detect gene mutations. Immunohistochemistry demonstrated sclerosing pneumocytomas, and NGS showed an IDH1 mutation. Eventually, the patient developed lung metastases for which rethoracotomy was performed. The differentiation of sclerosing pneumocytoma from lung cancer is a diagnostic challenge, and sclerosing pneumocytoma should be considered in the differential diagnosis of pulmonary nodules. Gene mutation analysis does not always show classical and common mutations, which should be kept in mind when interpreting its results.
硬化性肺细胞瘤是一种罕见的良性肺肿瘤,主要影响 40-70 岁的亚洲女性,大多数为不吸烟者。我们报告了一例 72 岁白人女性,患有手部软骨肉瘤,随后出现多个双侧进行性肺结节,疑似肺转移。进行了分期肺切除术,并通过对切除标本的免疫组织化学分析确认了病理诊断。下一代测序(NGS)用于检测基因突变。免疫组化显示硬化性肺细胞瘤,NGS 显示 IDH1 突变。最终,患者发生了肺癌转移,为此进行了再次开胸手术。硬化性肺细胞瘤与肺癌的鉴别诊断具有挑战性,在肺结节的鉴别诊断中应考虑到硬化性肺细胞瘤。基因突变分析并不总是显示经典和常见的突变,在解释其结果时应牢记这一点。